Construction of a Biocompatible Decellularized Porcine Hepatic Lobe for Liver Bioengineering
Abstract
OBJECTIVE: One of the major obstacles in applying decellularized organs for clinical use is the recellularization step, during which huge numbers of cells are required to develop whole livers. We established a simple protocol for constructing a bioartificial hepatic lobe and investigated its biocompatibility. METHODS: The right lateral lobe of porcine liver was decellularized using 0.1% sodium dodecyl sulfate through the right branch of the portal vein. Decellularized lobes were evaluated by histological and biochemical analyses. DNA content was quantified to validate the decellularization protocol. The presence of immunogenic and pathogenic antigens was checked to exclude potential rejection and thrombosis after xenotransplantation. Xeno-reactivity of decellularized tissue against human peripheral blood mononuclear cells was examined. Cytotoxicity was evaluated against hepatocarcinoma cells. Finally, scaffolds were incubated in collagenase for biodegradation testing. RESULTS: The decellularized lobe preserved the three-dimensional architecture, ultrastructure, extracellular matrix components, and vasculature. Scaffolds were almost depleted of DNA in addition to antigenic and pathogenic antigens, which are considered barriers to xenotransplantation. The human immune response against scaffolds was considered non-significant. Our matrices were biocompatible and biodegradable. CONCLUSIONS: We successfully developed a non-cytotoxic, non-immunogenic, and biodegradable porcine hepatic lobe for future liver regeneration and bioengineering.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Decellularization has demonstrated efficient capability in removing or reducing the alpha-gal content from porcine liver.
“Decellularization has demonstrated efficient capability in removing or reducing the alpha-gal content from porcine liver [[67], [68], [69]].”
From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [67]
Cites
The use of whole organ decellularization for the generation of a vascularized liver organoid
Baptista, P. M., Siddiqui, M. M., Lozier, G., Rodriguez, S. R., Atala, A., & Soker, S. (2011) · Hepatology · doi:10.1002/hep.24067 · Cited by 681 · see citing works
Immunogenicity of Decellularized Porcine Liver for Bioengineered Hepatic Tissue
Mirmalek-Sani, S.-H., Sullivan, D. C., Zimmerman, C., Shupe, T. D., & Petersen, B. E. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.05.002 · Cited by 115 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application
Hussein, K. H., Park, K.-M., Kang, K.-S., & Woo, H.-M. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.05.068 · Cited by 218 · see citing works
Self-citationHussein, K. H., Park, K.-M., Yu, L., Song, S.-H., Woo, H.-M., & Kwak, H.-H. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.12.029 · Cited by 44 · see citing works
Self-citationHussein, K. H., Ahmadzada, B., Correa, J. C., Sultan, A., Wilken, S., Amiot, B., & Nyberg, S. L. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.06.001 · Cited by 28 · see citing works
“Decellularization has demonstrated efficient capability in removing or reducing the alpha-gal content from porcine liver [67 – 69].”
BackgroundSelf-citation
- Authors
- Hussein, K. H., Park, K. M., Kim, H. M., Teotia, P. K., Ghim, J. H., & Woo, H. M.
- Affiliations
- Kangwon National University (KR)
- Brigham and Women's Hospital (US)
- Corresponding author
- Woo, Heung M.
- Venue
- The International Journal of Artificial Organs
- Publisher
- SAGE Publications
- Published
- 2015-01-03
- Volume
- 38
- Issue
- 2
- Pages
- 96-104
- ISSN
- 0391-3988 (ISSN-L)
- 1724-6040
- OpenAlex
- W2000165518
- Cited by
- 15
- References
- 2
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 6
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The International Journal of Artificial Organs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Keywords
- porcine liver, xenotransplantation, biocompatibility, immunogenicity, extracellular matrix, liver regeneration, cytotoxicity
- MeSH terms
- Animals, Biocompatible Materials, Extracellular Matrix, Graft Rejection, Graft Survival, Humans, Liver, Sodium Dodecyl Sulfate, Time Factors, Transplantation, Heterologous, Liver Transplantation, Collagenases, Liver, Artificial, Transplantation Tolerance, Tissue Engineering, Sus scrofa, Tissue Scaffolds, Hep G2 Cells, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review